Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LifeSignals, Inc.

https://lifesignals.com/

Latest From LifeSignals, Inc.

Post-COVID-19 Consumer Preferences Provide Roadmap For Strategy Across Health Care Sectors

Post-COVID, a consumer’s home as point of care has led to greater acceptance for health gadgets while shifting preferences away from injectables, shows a new study, which has pointers for pharma strategy. With anxiety over the pandemic continuing, mental telehealth solutions are ripe for the picking.

Market Intelligence Business Strategies

Post-COVID-19 Consumer Preferences A Guide For Pharma Strategy

Post-COVID, a consumer’s home as point of care has led to greater acceptance for health gadgets while shifting preferences away from injectables, shows a new study, which has pointers for pharma strategy. With anxiety over the pandemic continuing, mental telehealth solutions are ripe for the picking, it adds.

Digital Health Coronavirus COVID-19

LifeSignals Receives US FDA Clearance To Market ECG Remote Monitoring Platform

LifeSignals received 510(k) clearance for its Wireless Medical Biosensor LP1250, which can be integrated into third-party devices to remotely monitor patients for common cardiac arrythmias.

Approvals Commercial
See All

Company Information

  • Industry
  • Medical Devices
  • Other Names / Subsidiaries
    • HealthMicro
    • Hmicro Inc.
UsernamePublicRestriction

Register